会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • Methods and compositions for controlling body weight and appetite
    • 用于控制体重和食欲的方法和组合物
    • US20070225351A1
    • 2007-09-27
    • US11603974
    • 2006-11-21
    • Arnold LippaJoseph EpsteinAnthony BasileJoseph Tizzano
    • Arnold LippaJoseph EpsteinAnthony BasileJoseph Tizzano
    • A61K31/403C07D209/52
    • C07D209/52A61K31/403
    • The present invention provides novel compositions and methods for the controlling appetite and weight and/or treating obesity using a (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or related compound. The invention also provides novel compositions and methods for treating or preventing disorders related to or complicated by excessive body weight or obesity, including coronary heart disease, osteoarthritis, osteoporosis, dislipidemias, gout, atherosclerosis, joint pain, sexual and fertility problems, respiratory problems, gall bladder disease, skin conditions, hypertension, diabetes, stroke, pulmonary embolism, sleep apnea, idiopathic intracranial hypertension, lower extremity venous stasis disease, gastro-esophageal reflux, urinary stress incontinence, metabolic syndrome, insulin resistance and cancer. The methods and compositions of the invention may employ a (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or related compound alone, or in combination with a second anti-appetite or anti-obesity agent.
    • 本发明提供了使用(+)-1-(3,4-二氯苯基)-3-氮杂双环[3.1.0]己烷或相关化合物来控制食欲和体重和/或治疗肥胖症的新型组合物和方法。 本发明还提供了用于治疗或预防与体重过重或肥胖相关或复杂的疾病的新型组合物和方法,包括冠心病,骨关节炎,骨质疏松症,血脂异常,痛风,动脉粥样硬化,关节疼痛,性和生殖问题,呼吸问题, 胆囊疾病,皮肤病,高血压,糖尿病,中风,肺栓塞,睡眠呼吸暂停,特发性颅内高压,下肢静脉淤滞疾病,胃食管反流,尿失禁,代谢综合征,胰岛素抵抗和癌症。 本发明的方法和组合物可以单独使用(+)-1-(3,4-二氯苯基)-3-氮杂双环[3.1.0]己烷或相关化合物,或与第二抗食欲或抗 - 肥胖剂。
    • 4. 发明申请
    • (-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders
    • ( - ) - 1-(3,4-二氯苯基)-3-氮杂环[3.1.0]己烷及其组合物,以及用于治疗酒精相关疾病
    • US20060173064A1
    • 2006-08-03
    • US11254242
    • 2005-10-18
    • Arnold LippaAnthony BasileJoseph Epstein
    • Arnold LippaAnthony BasileJoseph Epstein
    • C07D209/52A61K31/403
    • C07D209/52A61K31/403
    • The present invention relates to (−)-1-(3,4-dichlorophenyl )-3-azabicyclo[3.1.0]hexane and pharmaceutically acceptable salts thereof, compositions comprising (−)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or a pharmaceutically acceptable salt thereof, and methods for treating or preventing a disorder alleviated by inhibiting dopamine reuptake. In certain embodiments the methods and compositions of the invention are effective for treating attention-deficit disorder, depression, obesity, Parkinson's disease, a tic disorder, and/or an addictive disorder. In more detailed embodiments, methods and compositions of the invention are provided for treating an alcohol-related addictive disorder, for example alcohol abuse, alcohol dependence, excess alcohol consumption, and/or alcohol withdrawal. The (−)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or pharmaceutically acceptable salt thereof may be employed within the methods and compositions of the invention in a form or composition that is substantially free of its corresponding (+)-enantiomer.
    • 本发明涉及( - ) - 1-(3,4-二氯苯基)-3-氮杂双环[3.1.0]己烷及其药学上可接受的盐,其包含( - ) - 1-(3,4-二氯苯基) 3-氮杂双环[3.1.0]己烷或其药学上可接受的盐,以及用于治疗或预防通过抑制多巴胺再摄取而减轻的病症的方法。 在某些实施方案中,本发明的方法和组合物对于治疗注意力缺陷障碍,抑郁症,肥胖,帕金森病,抽动障碍和/或成瘾性障碍是有效的。 在更详细的实施方案中,提供本发明的方法和组合物用于治疗醇相关的成瘾症,例如酒精滥用,酒精依赖,过量饮酒和/或戒酒。 ( - ) - 1-(3,4-二氯苯基)-3-氮杂双环[3.1.0]己烷或其药学上可接受的盐可以在本发明的方法和组合物中以基本上不含 其对应的(+) - 对映异构体。
    • 6. 发明申请
    • Methods and compositions for the treatment of metabolic syndrome
    • 用于治疗代谢综合征的方法和组合物
    • US20080081781A1
    • 2008-04-03
    • US11784294
    • 2007-04-06
    • Arnold LippaJian-Dong JiangJing WeiWei-Jia KongLi-Xun ZhaoDan-Qing Song
    • Arnold LippaJian-Dong JiangJing WeiWei-Jia KongLi-Xun ZhaoDan-Qing Song
    • A61K31/4355A61K31/555A61K38/28A61P3/00
    • A61K31/4375
    • Methods and compositions containing a berberine compound or berberine related or proto-berberine or derivative compound are provided for the prevention and treatment of metabolic and cardiovascular disorders including metabolic syndrome, hyperlipidemia, obesity, diabetes, insulin resistance, hyperglycemia, hypertension and elevated cholesterol in mammalian subjects. The methods and compositions of the invention are effective for prevention and treatment of metabolic syndrome, hyperlipidemia, obesity, diabetes, insulin resistance, hyperglycemia, hypertension and elevated cholesterol. Additional compositions and methods are provided which employ a berberine compound or berberine related or derivative compound in combination with a second anti-therapeutic agent to yield more effective treatment tools against metabolic disorders, and/or dual activity therapeutic methods and formulations useful to prevent or reduce hyperlipidemia and/or hyperglycemia and one or more causal or related symptoms or conditions associated with hyperlipidemia and/or hyperglycemia in mammalian subjects.
    • 提供含有小檗碱化合物或小檗碱相关或原小​​檗碱或衍生化合物的方法和组合物用于预防和治疗哺乳动物代谢和心血管疾病,包括代谢综合征,高脂血症,肥胖,糖尿病,胰岛素抵抗,高血糖,高血压和升高的胆固醇 科目。 本发明的方法和组合物可有效预防和治疗代谢综合征,高脂血症,肥胖症,糖尿病,胰岛素抵抗,高血糖症,高血压和升高的胆固醇。 提供了额外的组合物和方法,其使用小檗碱化合物或小檗碱相关或衍生化合物与第二抗治疗剂组合以产生针对代谢紊乱的更有效的治疗工具,和/或可用于预防或减少的双重活性治疗方法和制剂 高脂血症和/或高血糖症和哺乳动物受试者中与高脂血症和/或高血糖相关的一个或多个因果或相关症状或病症。